Over Active Bladder (OAB) in Women – The Newest OTC Indication
by Stephen Mann
Mann S. Over Active Bladder (OAB) in Women – The Newest OTC Indication.
SelfCare 2013; 4(2):21-22
Editorial Board: Professor R W Soller, Dr S G Mann,
Dr J D Irvin, Dr R P Juhl, Dr J Raine, Professor P Noyce, Professor A Blenkinsopp,
Dr D B Nash, Professor C Bond.
A commentary on the latest switch to non-prescription status in the US, which introduces a new indication to self-care - over active bladder - and allows a reappraisal of current regulatory decision making and practice.
Also in this issue, a paper examining consumer preference in how on-line health messages are presented.
by Stephen Mann
Mann S. Over Active Bladder (OAB) in Women – The Newest OTC Indication.
SelfCare 2013; 4(2):21-22
Free Text
+
by R William Soller
Soller RW. Regulatory Science Implications of Expanded Medication Access for Treatment of Overactive Bladder. SelfCare 2013:4(2):23-37
Review
+
by Sarah Pasetes, Roshini Epasinghe
Pasetes S, Epasinghe R. Use of Label Comprehension Study Design to Assess Consumer Preferences for E-Health Communications from Health Practitioners. SelfCare 2013;4(2):38-60
Article
+
A selection of newly published papers on self-care from the worldwide literature
Every week, we will provide a brief summary and a link to the published abstract of newly published papers selected from the worldwide literature as being of particular interest to the SelfCare community.
Free Text
+
by de Vos WM, Engstrand L, Drago L, Reid G, Schauber J, Hay R, Mendling W, Schaller M, Spiller R, Gahan CG, Rowland I.
SelfCare 2012;3(S1):1-68
Supplement
+Displaying articles 5 of 5
Send an email with details of your academic post to
editor@selfcarejournal.com
and we will arrange free access to SelfCare